HORMONE REPLACEMENT THERAPY IN WOMEN WITH A HISTORY OF BREAST-CARCINOMA

被引：13

作者：

ISAACS, CJD

SWAIN, SM

机构：

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1994年 / 8卷 / 01期

关键词：

D O I：

10.1016/S0889-8588(18)30195-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：179 / 195

页数：17

共 128 条

[1]

ABE O, 1992, LANCET, V339, P71

[2]

ALLEGRA JC, 1985, SEMIN ONCOL, V12, P3

[3] ORAL-CONTRACEPTIVE USE INFLUENCES RESTING BREAST PROLIFERATION [J].

ANDERSON, TJ ;

BATTERSBY, S ;

KING, RJB ;

MCPHERSON, K ;

GOING, JJ .

HUMAN PATHOLOGY, 1989, 20 (12) :1139-1144

[4] CELL TURNOVER IN THE RESTING HUMAN-BREAST - INFLUENCE OF PARITY, CONTRACEPTIVE PILL, AGE AND LATERALITY [J].

ANDERSON, TJ ;

FERGUSON, DJP ;

RAAB, GM .

BRITISH JOURNAL OF CANCER, 1982, 46 (03) :376-382

[5]

[Anonymous], 1992, Lancet, V339, P1

[6]

[Anonymous], 1991, ANN NY ACAD SCI

[7] THE RISK OF BREAST-CANCER AFTER ESTROGEN AND ESTROGEN PROGESTIN REPLACEMENT [J].

BERGKVIST, L ;

ADAMI, HO ;

PERSSON, I ;

HOOVER, R ;

SCHAIRER, C .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (05) :293-297

[8]

BERNSTEIN L, 1985, J NATL CANCER I, V74, P741

[9]

BOYD NF, 1981, JNCI-J NATL CANCER I, V67, P785

[10] SERUM HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL IN WOMEN USING ORAL-CONTRACEPTIVES, ESTROGENS AND PROGESTINS [J].

BRADLEY, DD ;

WINGERD, J ;

PETITTI, DB ;

KRAUSS, RM ;

RAMCHARAN, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (01) :17-20

← 1 2 3 4 5 6 7 8 9 10 →